| Literature DB >> 20213306 |
Michael Groessl1, Yury O Tsybin, Christian G Hartinger, Bernhard K Keppler, Paul J Dyson.
Abstract
The binding of the ruthenium-based antipan> class="Disease">cancer drug candidates KP1019, NAMI-A and RAPTA-T towards different double-stranded oligonucleotides was probed by electrospray ionisation mass spectrometry and compared with that of the widely used platinum-based chemotherapeutics cisplatin, carboplatin and oxaliplatin. It was found that the extent of adduct formation decreased in the following order: cisplatin > oxaliplatin > NAMI-A > RAPTA-T > carboplatin > KP1019. In addition to the characterisation of the adducts formed with the DNA models, the binding sites of the metallodrugs on the oligonucleotides were elucidated employing top-down tandem mass spectrometry and were found to be similar for all the metallodrugs studied, irrespective of the sequence of the oligonucleotide. A strong preference for guanine residues was established.Entities:
Mesh:
Substances:
Year: 2010 PMID: 20213306 PMCID: PMC6485486 DOI: 10.1007/s00775-010-0635-0
Source DB: PubMed Journal: J Biol Inorg Chem ISSN: 0949-8257 Impact factor: 3.358